$1.28
0.010.79%
Pre-Market: 4:03 AM EDT
Repare Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Repare Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.81 | $-0.87 | 6.90 % |
Q2 | 2024-08-06 | $-0.82 | $-0.87 | 5.75 % |
Q1 | 2024-05-07 | $0.30 | $0.02 | 1400.0 % |
Q4 | 2024-02-28 | $-0.67 | $-0.46 | -45.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $0 | $2.91M | -100.0 % |
Q2 | 2024-08-06 | $1.07M | $2.92M | -63.3 % |
Q1 | 2024-05-07 | $52.40M | $38.40M | 36.5 % |
Q4 | 2024-02-28 | $13.05M | $18.93M | -31.1 % |
Repare Therapeutics (RPTX) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.81, which beat the estimate of $-0.87.
The Actual Revenue was $0K, which missed the estimate of $2.9M.
Browse earnings estimates, EPS, and revenue on all stocks.